Any scale weight change during a BPC-157 protocol is more likely the result of training consistency, hydration habits, and nutrition than the peptide itself
The clinical investigations of results can correct the medical program
Injections are self-administered and subcutaneous (i.e., into a fatty area such as a thigh, an upper arm, or the belly)
However, full-length TB-4 is biologically fragile, expensive to synthesize, and has poor shelf stability, making it less practical for research or commercial use
A TUE would be granted if the criteria outlined in the International Standard for Therapeutic Use Exemptions are met
Data from: 2021 anti-doping testing figures